Oncolytics Biotech (ONCY) Amortizatization of Intangibles (2009 - 2010)
Oncolytics Biotech's (ONCY) quarterly Amortizatization of Intangibles came in at $3.6 million in Q2 2010, up 3900.0% year-on-year from $90375.0 in Q2 2009, and little changed on a QoQ basis from $3.6 million in Q1 2010.
Oncolytics Biotech (ONCY) Amortizatization of Intangibles (2009 - 2010) Analysis & Trends
Oncolytics Biotech (ONCY) has 2 years of Amortizatization of Intangibles data on file, last reported at $3.6 million in Q2 2010.
- On a quarterly basis, Amortizatization of Intangibles rose 3900.0% year-over-year to $3.6 million in Q2 2010; TTM through Jun 2010 was $10.8 million, a 2900.0% increase from a year earlier, with the FY2010 full-year figure at $3.6 million, up 1900.0% from the prior year.
- Amortizatization of Intangibles for Q2 2010 stood at $3.6 million, roughly flat from $3.6 million in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for ONCY reached as high as $3.6 million in Q3 2009 and fell as low as $90375.0 in Q1 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Oncolytics Biotech | 76.93 Mn | 76.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2010 | 3.62 Mn |
| Jun 30, 2010 | 3.62 Mn |
| Mar 31, 2010 | 3.62 Mn |
| Mar 31, 2010 | 3.62 Mn |
| Sep 30, 2009 | 3.62 Mn |
| Sep 30, 2009 | 3.62 Mn |
| Jun 30, 2009 | 90,375.00 |
| Jun 30, 2009 | 90,375.00 |
| Mar 31, 2009 | 90,375.00 |
| Mar 31, 2009 | 90,375.00 |